blindness from tirzepatide Vision loss risks in patients using popular GLP-1 medications raise concerns blindness and tirzepatide A small

Above, we summarized the peptides research-backed benefits and side effects, and illuminated worthwhile directions for future research

Data represent mean s.e.m

The lowest dose of 2.5 mg tirzepatide was the initiation dose for all patients and the dosages were up titrated and adjusted by the physicians based on individual patients glycemic and/or weight loss goal and adverse events of the treatment

However, some patients may benefit from temporary discontinuation, particularly those: In the dose-escalation phase Experiencing significant gastrointestinal symptoms With known gastroparesis or other conditions affecting gastric emptying With obesity complicated by GERD or hiatal hernia Undergoing procedures with higher aspiration risk For these higher-risk patients on once-weekly injectable semaglutide , some clinicians recommend discontinuation approximately one week (7 days) before elective surgery

Decide what you will order when you are not hungry or distracted

The GLP-1 program should be stored at the appropriate temperature to maintain its quality